Related Experiment Videos
Volume and time factors in interstitial gamma-ray therapy.
AJR. American Journal of Roentgenology
|January 1, 1976
Summary
Total dose, not dose rate, is critical in interstitial gamma-ray therapy. Larger lesions may require higher doses, challenging traditional radiation therapy assumptions for improved lesion control.
Area of Science:
- Radiation Oncology
- Medical Physics
- Oncology
Background:
- Established principles in interstitial gamma-ray implantation dictate relationships between time-dose and volume.
- Two classical assumptions guide treatment planning: dose reduction at high dose rates and dose decrease with increased volume.
Purpose of the Study:
- To critically examine the validity of two long-standing assumptions in interstitial gamma-ray therapy based on recent publications.
- To evaluate the necessity of total dose reduction at high dose rates and dose adjustment for varying lesion volumes.
Main Methods:
- Review and analysis of recent clinical publications and experiences in interstitial gamma-ray therapy.
- Comparison of current clinical findings with traditional time-dose and volume-dose principles.
Main Results:
- The assumption that total dose must be reduced when dose rate exceeds 6,000-7,000 rads/seven days is not clinically substantiated.
- Total dose appears to be the primary determinant of treatment efficacy; dose rates can be increased significantly without altering total dose.
- The principle of decreasing dose with increasing volume is not rigidly applicable to interstitial gamma-ray therapy; larger lesions may necessitate higher doses.
Conclusions:
- Total dose is the critical parameter in interstitial gamma-ray therapy, not the dose rate.
- Dose compensation for volume is not always necessary; larger lesions may require higher doses for effective treatment.
- Adherence to these revised principles can lead to a higher percentage of controlled lesions.